Electronic transmission of individual case safety reportshttps://legemiddelverket.no/english/pharmacovigilance/electronic-transmission-of-individual-case-safety-reportsElectronic transmission of individual case safety reports As of November 2005 the Norwegian Medicines Agency (NOMA) only accepts individual case safety reports (ICSRs) electronically through Eudravigilance gateway. 438
Frequently asked questions (FAQ) – Electronic transmission of individual case safety reportshttps://legemiddelverket.no/english/pharmacovigilance/frequently-asked-questions-faq-electronic-transmission-of-individual-case-safety-reportsFrequently asked questions (FAQ) – Electronic transmission of individual case safety reportsThis information is meant as guidance on specific topics, and reflects frequently asked questions from the marketing authorisation holders (MAHs). 439
Information regarding the transfer to a new national pharmacovigilance databasehttps://legemiddelverket.no/nyheter/information-regarding-the-transfer-to-a-new-national-pharmacovigilance-databaseInformation regarding the transfer to a new national pharmacovigilance databaseNoMA is in the process of acquiring a new pharmacovigilance database. According to the current plan, NoMA will transfer from the old database to the new system by the end of October 2017. 1354
Questions and answers about the introduction of the new pharmacovigilance legislationhttps://legemiddelverket.no/english/pharmacovigilance/questions-and-answers-about-the-introduction-of-the-new-pharmacovigilance-legislationQuestions and answers about the introduction of the new pharmacovigilance legislation440
What is pharmacovigilancehttps://legemiddelverket.no/english/pharmacovigilance/what-is-pharmacovigilanceWhat is pharmacovigilancePharmacovigilance is an important tool for ensuring safe and effective drugs. The purpose is to gather information about safety in clinical use and shorten the time until the safety profile of a drug is well known.437